Quantcast
Last updated on April 20, 2014 at 17:20 EDT

Latest HIV/AIDS Stories

2014-04-08 08:32:29

SYDNEY, April 8, 2014 /PRNewswire/ -- For the second year in a row, ide's innovative and world-class product design has been recognised at the 2014 Medical Design Excellence Awards (MDEA). The AtomoRapid(TM) HIV is one of three finalists in the In Vitro Diagnostic Products and Systems category of this year's MDEA, the Medtech industry's leading international awards. AtomoRapid(TM) HIV is the world's first integrated rapid HIV blood test, offering a simple, reliable solution for...

2014-04-08 08:31:28

Seattle Non-Profit Receives Major Challenge Grant from the Bill & Melinda Gates Foundation SEATTLE, April 8, 2014 /PRNewswire/ -- Lifelong AIDS Alliance (Lifelong), a Seattle-based organization that delivers food, housing, and health services to people with chronic illnesses such as HIV, received news of a $500,000 challenge grant from the Bill & Melinda Gates Foundation. The grant will support capacity expansion of their food program, Chicken Soup Brigade. "As part of the...

2014-04-07 23:28:27

Advocates for Youth Supports Young People Across the Country Who are Transforming the Way the World Sees HIV & AIDS on National Youth HIV & AIDS Awareness Day Washington, DC (PRWEB) April 07, 2014 According to the U.S. Centers for Disease Control and Prevention, nearly 26 percent of all new HIV infections occur among young people ages 13 to 24 years old. Of those new infections, African-American youth and young men who have sex with men (YMSM) are most at risk: nearly 60 percent...

2014-04-03 12:58:10

New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation, suggest a new strategy in the fight against HIV and AIDS. Despite the effectiveness of antiviral therapies at suppressing HIV, the virus still persists indefinitely at low levels in infected patients who are diligent about taking their medications. "Current therapies fail to cure...

2014-04-02 20:22:23

LOS ANGELES, April 2, 2014 /PRNewswire-USNewswire/ -- On March 19 the Centers for Disease Control and Prevention (CDC) awarded $115 million over five years to 21 organizations to provide technical assistance to health departments and organizations implementing CDC's new prevention strategies and improving health outcomes for people living with HIV/AIDS. Not one of these organizations is a Black organization. The effect of this decision is that Black organizations have been locked out...

2014-04-02 12:07:35

Researchers offer immediate steps to address rise in deaths There are important parallels between the early years of the HIV/AIDS epidemic and the current epidemic of opioid addiction - ones that could trigger a significant shift in opioid addiction prevention, diagnosis and treatment. These are the findings of a comparative review of HIV/AIDS and addiction by researchers Josiah D. Rich, M.D., M.P.H., director of the Center for Prisoner Health and Human Rights, based at The Miriam...

2014-04-01 16:25:28

Elizabeth Glaser Pediatric AIDS Foundation Applauds Agreement between the Medicines Patent Pool and ViiV Healthcare WASHINGTON, April 1, 2014 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare to increase access to dolutegravir (DTG), a promising new antiretroviral (ARV) medication. This agreement will allow generic manufacturers to scale up production of...

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2014-04-01 16:25:15

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/ -- ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug...

2014-04-01 14:04:36

Pressure from counselors and perceived ineffectiveness & irrelevance of intervention keep young adults from returning to follow-up sessions Keeping young people in human immunodeficiency virus (HIV) prevention programs is a major goal in reducing the incidence of HIV, and multi-session interventions are often more effective than single-sessions. But according to a new study from the Annenberg School for Communication, the way these programs are designed and implemented may turn off the...


Latest HIV/AIDS Reference Libraries

Sooty Mangabey, Cercocebus atys
2014-04-17 14:17:40

The Sooty Mangabey (Cercocebus atys) is an Old World monkey located in forests from Senegal east to Ghana. While overall rated as Vulnerable, the eastern race, lunulatus, known also as the White-Crowned, White-Naped, or White-Collared Mangabey, is considered to be Endangered by the IUCN Red List. They Sooty Mangabey reside in both old growth and secondary forests in addition to flooded, dry, swamp, mangrove, and gallery forests. The primate is arboreal and diurnal. They are omnivores whose...

Journal of Acquired Immune Deficiency Syndromes
2012-05-16 12:01:26

The Journal of Acquired Immune Deficiency Syndromes is a peer-reviewed medical journal established in 1988 and is currently published by Lippincott Williams & Wilkins. The journal was renamed ‘Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology’ in 1995, and then returned to its original title in 1999. The journal was the official publication of the International Retrovirology Association until 2000. This journal covers aspects of research in HIV/AIDS, including...

AIDS
2012-05-07 07:38:24

AIDS is a peer-reviewed scientific journal published 18 times yearly by Lippincott Williams & Wilkins, London, UK. It was established in 1987 and is the official journal of the International AIDS Society. It covers all aspects of HIV and AIDS research, including basic science, clinical trials, epidemiology, and social science. As of May 2012, the editor-in-chief is Jay A. Levy. AIDS has been cited as the most read journal in its area of science and has the highest impact of all...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

0_336928514f8c16d00d00e956be85245d
2011-02-17 15:06:48

Kaposi's sarcoma-associated herpesvirus (KSHV) one of seven currently known human cancer virus, is also the eighth human herpesvirus. Kaposi's sarcoma, caused by the virus, is common in AIDS patients, primary effusion lymphoma, and some types of multicentric Castelman's disease. Moritz Kaposi discovered the blood vessel tumor, in 1872, which would eventually be names Kaposi's sarcoma. It was originally though that KS was of Jewish and Mediterranean origins until it was found to be common...

More Articles (6 articles) »